Here, we show that up to 10 years before diagnosis, higher plasma levels of TNFRSF17 and TNFRSF13B, receptors for BAFF and APRIL, were strong, specific predictors of increased risk of MM and MGUS, respectively. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.